Personal Genome Diagnostics has appointed Maria Chan vice president of regulatory strategy. Chan will oversee all regulatory activities at PGDx and will help shape the company's strategy for moving products through regulatory processes. Chan previously served as director of the Division of Immunology & Hematology Devices at the Center for Devices & Radiological Health, in the US Food and Drug Administration's Office of In Vitro Diagnostics & Radiological Health. She also served as a scientific reviewer and team leader of immunology, genetics, and molecular diagnostic devices, and as associate division director for the immunology branch at the FDA. Prior to the FDA, Chan served in various positions at Children's National Health System, the George Washington University Medical Center, and the Johns Hopkins University School of Medicine.